| 539 |
Centers for Disease Control and Prevention |
Html |
en |
School-Located Vaccination Planning Materials and Templates |
Templates and materials for planners to use when hosting school-located influenza vaccinations - CDC |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 6862 |
Centers for Disease Control and Prevention |
Html |
en |
Notes from the Field: Severe Hand, Foot, and Mouth Disease Associated with Coxsackievirus A6 - Alabama, Connecticut, California, and Nevada, November 2011-February 2012 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| mmwrq@cdc.gov. | 0.69314 |
| CDC | 0.737575 |
| Maria L. Salas | 0.731847 |
| extensive rash | 0.739789 |
| Human Services | 0.725798 |
| common viral illness | 0.761775 |
| MMWR HTML versions | 0.733795 |
| U.S. Department | 0.725385 |
| international outbreaks | 0.759569 |
| mouth disease | 0.69501 |
| electronic PDF version | 0.734239 |
| state health departments | 0.747812 |
| Zoonotic Infectious Diseases | 0.730834 |
| National Center | 0.723419 |
| CVA6 strains | 0.734328 |
| patients | 0.741468 |
| serotype coxsackievirus | 0.697759 |
| mild febrile illness | 0.749574 |
| typical HFMD | 0.721529 |
| Marie Louise Landry | 0.724876 |
| HFMD | 0.837631 |
| Mary G. McIntyre | 0.733123 |
| original paper copy | 0.728053 |
| Washoe County Health | 0.74921 |
|
| Julie A. Kulhanjian | 0.730351 |
| transcriptase–polymerase chain reaction | 0.744949 |
| Tara L. Greenhow | 0.733443 |
| California Department | 0.689728 |
| Pediatrics Medical Group | 0.7318 |
| Public Health | 0.758508 |
| CVA6-associated HFMD | 0.716431 |
| United States | 0.974984 |
| U.S. Government Printing | 0.740548 |
| original MMWR paper | 0.739582 |
| New Haven Hospital | 0.734589 |
| child care facility | 0.762118 |
| enterovirus laboratory diagnosis | 0.746359 |
| child care | 0.807487 |
| Lauren J. Stockman | 0.837532 |
| U.S. cases | 0.735184 |
| CVA6 HFMD | 0.730929 |
| child care settings | 0.746811 |
| San Francisco | 0.727051 |
| atypical rash | 0.749676 |
| Coxsackievirus A6 | 0.696841 |
| rash variables | 0.740366 |
| initial symptom onset | 0.746639 |
| Dianna M. Blau | 0.733949 |
|
CLICK HERE |
| 6943 |
Centers for Disease Control and Prevention |
Html |
en |
The Importance of Folic Acid: Anifa's Story | CDC Features |
Worldwide, more than 300,000 babies are born with serious birth defects of the brain and spine each year. Read Anifa's story and find out what CDC is doing to help. |
| pregnancies | 0.224902 |
| common neural tube | 0.336824 |
| CDC | 0.236683 |
| spina bifida | 0.882299 |
| lifelong medical challenges | 0.392011 |
| productive lives | 0.253071 |
| neural tube defects | 0.997133 |
| mcg | 0.240323 |
| significant cause | 0.261072 |
| children | 0.251409 |
| proper care | 0.254891 |
| National Center | 0.251425 |
| global initiative | 0.250216 |
| chest | 0.211773 |
| Birth Defects COUNT | 0.342778 |
| pregnancy | 0.221173 |
| Worldwide | 0.223764 |
| old girl | 0.25856 |
| critical step | 0.252539 |
| Anifa | 0.399005 |
| women | 0.231304 |
| folic acid fortification | 0.339667 |
| Developmental Disabilities | 0.252266 |
| woman | 0.218717 |
| death | 0.237424 |
|
| United States | 0.410581 |
| folic acid intake | 0.33686 |
| protection | 0.211206 |
| babies | 0.269162 |
| best medical care | 0.293616 |
| new cells | 0.251545 |
| world | 0.212098 |
| paper | 0.211418 |
| diapers | 0.21216 |
| stroller | 0.213752 |
| spinal cord | 0.257136 |
| folic acid | 0.569429 |
| primary health center | 0.304752 |
| lifelong disability | 0.253164 |
| folic acid daily | 0.337981 |
| reproductive age | 0.251906 |
| spine | 0.241037 |
| brain | 0.224009 |
| birth defects | 0.444071 |
| emotional impacts | 0.254245 |
| family | 0.22314 |
| movement | 0.211288 |
| bladder control | 0.25943 |
| surgery | 0.220844 |
|
CLICK HERE |
| 7573 |
Centers for Disease Control and Prevention |
Html |
en |
Progress Toward Poliomyelitis Eradication - Afghanistan and Pakistan, January 2011-August 2012 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| sewage samples | 0.60021 |
| areas | 0.631626 |
| Polio Eradication Dept | 0.585949 |
| national non-polio AFP | 0.583578 |
| AFP cases | 0.658823 |
| Administered Tribal Areas | 0.599676 |
| OPV doses | 0.592801 |
| positive sewage sample | 0.619303 |
| polio eradication activities | 0.636394 |
| latest positive sewage | 0.618269 |
| children | 0.671737 |
| vaccination teams | 0.611939 |
| Global Polio Eradication | 0.636587 |
| Global Immunization Div | 0.589955 |
| national emergency action | 0.738984 |
| WPV1 cases | 0.650573 |
| Pakistan Polio Eradication | 0.623916 |
| emergency action plans | 0.646951 |
| Polio Eradication Initiative | 0.634524 |
| South Region | 0.638368 |
| high-risk districts | 0.660236 |
| polio cases | 0.60824 |
| recent confirmed cases | 0.582394 |
| indigenous wild poliovirus | 0.597403 |
| WPV transmission areas | 0.6014 |
|
| Federally Administered Tribal | 0.593349 |
| conflict-affected areas | 0.589461 |
| WPV cases | 0.982919 |
| AFP surveillance | 0.655855 |
| emergency action plan | 0.662958 |
| target age group | 0.587522 |
| Afghanistan | 0.770225 |
| polio eradication | 0.816692 |
| FATA | 0.595533 |
| wild poliovirus | 0.602386 |
| WPV3 cases | 0.592201 |
| Pakistan | 0.819957 |
| non-polio AFP | 0.689999 |
| latest confirmed case | 0.622298 |
| endemic polio transmission | 0.58449 |
| non-polio AFP cases | 0.644943 |
| Afghanistan National Polio | 0.628814 |
| Khyber Agency | 0.623191 |
| targeted children | 0.596129 |
| WPV type | 0.592988 |
| World Health Assembly | 0.600334 |
| oral polio vaccine | 0.635438 |
| Global Polio Laboratory | 0.582097 |
| WPV transmission | 0.665007 |
|
CLICK HERE |
| 7731 |
Centers for Disease Control and Prevention |
Html |
en |
Take-Home Lead Exposure Among Children with RelativesEmployed at a Battery Recycling Facility - Puerto Rico,2011 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| Puerto Rico | 0.682114 |
| CDC | 0.595877 |
| blood lead tests | 0.614376 |
| lead prevalence study | 0.5553 |
| lead processing facilities | 0.471505 |
| blood lead | 0.955783 |
| high-risk lead exposure | 0.484784 |
| recycled lead smelters | 0.478294 |
| blood lead threshold | 0.500661 |
| lead recycling facility | 0.497083 |
| dust lead level | 0.524532 |
| Lead Poisoning Prevention | 0.470181 |
| children | 0.762508 |
| child blood lead | 0.525303 |
| recycled lead | 0.49138 |
| EPA level | 0.475506 |
| vehicle dust samples | 0.53176 |
| additional blood lead | 0.524733 |
| elevated blls | 0.605036 |
| ТЕg/dL | 0.690704 |
| employee homes | 0.542042 |
| elevated lead levels | 0.494268 |
| blood lead screening | 0.656335 |
| average blood lead | 0.491491 |
|
| attention deficit/hyperactivity disorder | 0.476164 |
| BLLs | 0.713048 |
| blood lead level | 0.572474 |
| battery recycling facility | 0.799917 |
| blood lead prevalence | 0.671411 |
| blood lead testing | 0.518648 |
| lead screening clinics | 0.582647 |
| clean changing areas | 0.485159 |
| portable blood lead | 0.521309 |
| BLLs т‰Ѕ10 ТЕg/dL | 0.520336 |
| household environmental samples | 0.511055 |
| take-home lead exposure | 0.650751 |
| EPA | 0.501936 |
| home dust samples | 0.532481 |
| lead recycling smelter | 0.496381 |
| cross-sectional blood lead | 0.579595 |
| Environmental Protection Agency | 0.508072 |
| lead recycling facilities | 0.492634 |
| employees | 0.488307 |
| lead exposure | 0.748578 |
| voluntary blood lead | 0.610524 |
| blood lead levels | 0.545186 |
| lead dust | 0.538004 |
|
CLICK HERE |
| 8503 |
Centers for Disease Control and Prevention |
Html |
en |
MDRO Guideline:Glossary - HICPAC |
null |
|
|
CLICK HERE |
| 9292 |
Centers for Disease Control and Prevention |
Html |
es |
CDC - Preventing Chronic Disease: Volume 9, 2012: 12_0066 |
CDC - Wide Page example description goes here |
| health statistics vision | 0.511073 |
| per cápita | 0.947776 |
| Salud Comunitaria | 0.444536 |
| Human Services | 0.436569 |
| Health Rep | 0.432308 |
| America’s Health | 0.471445 |
| nivel per cápita | 0.464703 |
| Wisconsin Population Health | 0.452827 |
| comparative effectiveness | 0.439435 |
| yield significant savings | 0.422344 |
| public’s health | 0.436528 |
| population health | 0.546597 |
| health statistics | 0.513456 |
| High School districts | 0.420311 |
| Toward Community Health | 0.439269 |
| Community Health Improvement | 0.444823 |
| Estados Unidos | 0.426658 |
| CrossRef PubMed | 0.530425 |
| mayores gastos | 0.464499 |
| crédito per cápita | 0.45038 |
| Public Health Strategies | 0.445665 |
| salud pública | 0.699865 |
| subvención robert wood | 0.420277 |
| EstadÃsticas Vitales | 0.481771 |
| Wisconsin School | 0.420391 |
|
| Kindig D | 0.433699 |
| Public Health | 0.53906 |
| Centro Nacional | 0.425569 |
| us states | 0.436605 |
| Early Head Start | 0.473295 |
| Epidemiol Community Health | 0.439068 |
| Health Aff | 0.432338 |
| pago per cápita | 0.45046 |
| numerosos obstáculos | 0.420519 |
| How healthy could | 0.42134 |
| Human Services Revenue | 0.423785 |
| programa wic | 0.470914 |
| Community Health | 0.504282 |
| programas head start | 0.430354 |
| organiza datos | 0.436135 |
| Head Start | 0.567495 |
| ¿Los datos | 0.442806 |
| Wisconsin genera | 0.42384 |
| condados informen | 0.420299 |
| Comité Nacional | 0.480336 |
| State Budget Officers | 0.475905 |
| National Association | 0.43653 |
| Nutrición Complementaria | 0.43545 |
| Improve Health | 0.431481 |
|
CLICK HERE |
| 11259 |
Centers for Disease Control and Prevention |
Html |
es |
¿Tiene un alto riesgo deenfermarse gravemente a causa de la influenza? |
Algunas personas están en alto riesgo de presentar complicaciones graves a causa de la influenza (gripe), incluidos los niños pequeños, las personas de edad avanzada, las mujeres embarazadas y aquellos que tienen ciertas afecciones. La vacuna contra la influenza y el uso correcto de medicamentos antivirales contra la influenza son muy importantes para esas personas. |
| Archivo Apple Quicktime | 0.564291 |
| posibles complicaciones | 0.546619 |
| revista pediatrics | 0.507592 |
| Archivo Microsoft PowerPoint | 0.577039 |
| Archivo Adobe PDF | 0.562887 |
| alto riesgo | 0.52818 |
| amplias investigaciones | 0.523983 |
| Estados Unidos | 0.513179 |
|
| Archivo Microsoft | 0.760538 |
| Archivo Microsoft Word | 0.575132 |
| raras excepciones | 0.528348 |
| influenza causa decenas | 0.918876 |
| largo plazo | 0.513505 |
| Archivo Zip Comprimido | 0.562249 |
| obstructiva crónica | 0.5257 |
| larga duración | 0.520218 |
|
CLICK HERE |
| 11740 |
Centers for Disease Control and Prevention |
Html |
en |
Norovirus | Outbreaks Reported to NoroSTAT, Data | CDC |
chart showing number of cases of norovirus outbreaks. |
| *Incomplete outbreak data | 0.893782 |
| National Outbreak Reporting | 0.988592 |
| comparison | 0.253345 |
| NORS | 0.261968 |
| Illness Onset | 0.585789 |
| health department records | 0.769592 |
|
| start | 0.260062 |
| Confirmed Norovirus Outbreaks | 0.985753 |
| State Health Departments | 0.856171 |
| NoroSTAT network | 0.696552 |
| Virginia | 0.207286 |
|
CLICK HERE |
| 13118 |
Centers for Disease Control and Prevention |
Html |
en |
2014-2015 Seasonal Influenza Vaccine Safety | SeasonalInfluenza (Flu) | CDC |
Flu Vaccine Safety Information: Questions and Answers -- CDC |
| multiple flu vaccines | 0.526985 |
| Compensation Program | 0.254515 |
| CDC | 0.252433 |
| health care provider | 0.300195 |
| Page | 0.234986 |
| best way | 0.265154 |
| National Vaccine Injury | 0.387366 |
| flu vaccines | 0.719939 |
| nearest hospital | 0.258099 |
| pregnant women | 0.253279 |
| severe allergic reaction | 0.507309 |
| Common side effects | 0.26012 |
| federal government | 0.256289 |
| flu vaccination | 0.5255 |
| flu vaccine safety | 0.595774 |
| flu illness | 0.518571 |
| Vaccine Adverse Event | 0.390571 |
| behavior changes | 0.258741 |
| rare exceptions | 0.255027 |
| VAERS website | 0.264055 |
| medical product | 0.260897 |
| live virus | 0.260514 |
| certain criteria | 0.253059 |
| Guillain-Barré syndrome | 0.260685 |
| severe egg allergies | 0.30701 |
|
| severe allergic conditions | 0.321942 |
| visit Flu Vaccine | 0.563248 |
| United States | 0.255879 |
| age-appropriate influenza vaccine | 0.386834 |
| Drug Administration | 0.256023 |
| flu vaccine | 0.962013 |
| flu virus | 0.479765 |
| annual flu vaccination | 0.508546 |
| unusual conditions | 0.255358 |
| flu vaccine options | 0.572541 |
| spray flu vaccine | 0.624751 |
| medical setting | 0.253514 |
| GBS following flu | 0.556257 |
| inactivated virus | 0.260975 |
| extensive research | 0.267221 |
| primary systems | 0.25568 |
| people | 0.242043 |
| allergic reactions | 0.271923 |
| doctor | 0.246362 |
| nasal spray vaccine | 0.398562 |
| flu shot | 0.650118 |
| injectable flu vaccine | 0.617498 |
| good safety record | 0.324989 |
| high fever | 0.257514 |
|
CLICK HERE |